Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort.

Show simple item record

dc.contributor.author Wijker Naomi E en
dc.contributor.author Vidmar Suzanna en
dc.contributor.author Grimwood Keith en
dc.contributor.author Sly Peter D en
dc.contributor.author Byrnes Catherine A en
dc.contributor.author Carlin John B en
dc.contributor.author Cooper Peter J en
dc.contributor.author Robertson Colin F en
dc.contributor.author Massie R John en
dc.contributor.author Kemner van de Corput Mariette PC en
dc.contributor.author Cheney Joyce en
dc.contributor.author Tiddens Harm AWM en
dc.contributor.author Wainwright Claire E en
dc.contributor.author Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) and Follow-up of the ACFBAL (CF-FAB) study groups en
dc.contributor.author following investigators constitute the ACFBAL Study Investigators Group: en
dc.contributor.author following investigators constitute the CF FAB Study Investigators Group: en
dc.contributor.author Additional contributions: We are indebted to all current and former clinical and research staff from Queensland Children's Hospital, Brisbane: en
dc.date.accessioned 2020-11-11T19:19:34Z
dc.date.available 2020-11-11T19:19:34Z
dc.date.issued 2020-4-3 en
dc.identifier.issn 0903-1936 en
dc.identifier.uri http://hdl.handle.net/2292/53521
dc.description.abstract Little is known about early predictors of later cystic fibrosis (CF) structural lung disease. This study examined early predictors of progressive structural lung abnormalities in children who completed the Australasian CF Bronchoalveolar Lavage (ACFBAL) clinical trial at age 5-years and participated in an observational follow-up study (CF-FAB).Eight Australian and New Zealand CF centres participated in CF-FAB and provided follow-up chest computed-tomography (CT) scans for children who had completed the ACFBAL study with baseline scans at age 5-years. CT scans were annotated using PRAGMA-CF scoring. Ordinal regression analysis and linear regression were used to investigate associations between PRAGMA-CF (Perth-Rotterdam Annotated Grid Morphometric Analysis for CF) outcomes at follow-up and variables measured during the ACFBAL study.99 out of 157 ACFBAL children (mean±sd age 13±1.5 years) participated in the CF-FAB study. The probability of bronchiectasis at follow-up increased with airway disease severity on the baseline CT scan. In multiple regression (retaining factors at p<0.05) the extent of bronchiectasis at follow-up was associated with baseline atelectasis (OR 7.2, 95% CI 2.4-22; p≤ 0.001), bronchoalveolar lavage (BAL) log2 interleukin (IL)-8 (OR 1.2, 95% CI 1.05-1.5; p=0.010) and body mass index z-score (OR 0.49, 95% CI 0.24-1.00; p=0.05) at age 5 years. Percentage trapped air at follow-up was associated with BAL log2 IL-8 (coefficient 1.3, 95% CI 0.57-2.1; p<0.001) at age 5 years.The extent of airway disease, atelectasis, airway inflammation and poor nutritional status in early childhood are risk factors for progressive structural lung disease in adolescence. en
dc.format.medium Electronic-Print en
dc.language eng en
dc.publisher EUROPEAN RESPIRATORY SOC JOURNALS LTD en
dc.relation.ispartofseries The European respiratory journal en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.subject Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) and Follow-up of the ACFBAL (CF-FAB) study groups en
dc.subject following investigators constitute the ACFBAL Study Investigators Group: en
dc.subject following investigators constitute the CF FAB Study Investigators Group: en
dc.subject Additional contributions: We are indebted to all current and former clinical and research staff from Queensland Children's Hospital, Brisbane: en
dc.subject 1102 Cardiorespiratory Medicine and Haematology en
dc.subject 1114 Paediatrics and Reproductive Medicine en
dc.subject Clinical en
dc.subject Clinical Medicine and Science en
dc.subject Prevention en
dc.subject Lung en
dc.subject Rare Diseases en
dc.subject Cystic Fibrosis en
dc.subject Pediatric Research Initiative en
dc.subject Clinical Research en
dc.subject Pediatric en
dc.subject Congenital Disorders en
dc.subject Respiratory en
dc.subject 2.2 Factors relating to physical environment en
dc.subject Science & Technology en
dc.subject Life Sciences & Biomedicine en
dc.subject Respiratory System en
dc.subject YOUNG-CHILDREN en
dc.subject INFANTS en
dc.subject BRONCHIECTASIS en
dc.subject ADOLESCENCE en
dc.subject CT en
dc.subject 11 Medical And Health Sciences en
dc.title Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort. en
dc.type Journal Article en
dc.identifier.doi 10.1183/13993003.01694-2019 en
pubs.issue 4 en
pubs.volume 55 en
dc.date.updated 2020-10-02T03:31:29Z en
dc.rights.holder Copyright: The author en
pubs.author-url http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000531099900012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=6e41486220adb198d0efde5a3b153e7d en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Journal Article en
pubs.elements-id 798381 en
dc.identifier.eissn 1399-3003 en
pubs.number ARTN 1901694 en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics